BrightPath Biotherapeutics4594 
$0.36-1.92%24h
-1.92%24h
Global rank29427
Market cap$21.62M
Change 7d-3.77%
YTD Performance-40.70%
SP500 benchmarkUnderperform
P/E-0.01
P/S576.26
Revenue$37.51K
Earnings-$10.55M
Dividend yield-
EPS for BrightPath Biotherapeutics (4594)
BrightPath Biotherapeutics has an EPS of $-24.9. In 2022, the company made an earnings per share (EPS) of $-28.55. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for 4594
-
Value:-
EPS history for BrightPath Biotherapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$24.90 | -12.78% |
| 2022 | -$28.55 | -21.00% |
| 2021 | -$36.14 | -18.24% |
| 2020 | -$44.20 | - |
View the highest EPS stocks
